Allogene Therapeutics to Report Second Quarter 2023 Financial Results on August 2, 2023
Conference Call and Webcast Scheduled for 2:00 PM PT/5:00 PM ET SOUTH SAN FRANCISCO, Calif.,…
Conference Call and Webcast Scheduled for 2:00 PM PT/5:00 PM ET SOUTH SAN FRANCISCO, Calif.,…
Live Conference Call and Webcast at 8:30 a.m. ET PRINCETON, N.J., July 26, 2023 (GLOBE…
Live Conference Call and Webcast at 8:30 a.m. ET PRINCETON, N.J., July 26, 2023 (GLOBE…
SHANGHAI, China and PRINCETON, N.J., July 26, 2023 (GLOBE NEWSWIRE) — LianBio’s (Nasdaq: LIAN) partner,…
SHANGHAI, China and PRINCETON, N.J., July 26, 2023 (GLOBE NEWSWIRE) — LianBio’s (Nasdaq: LIAN) partner,…
FREMONT, CA, July 26, 2023 (GLOBE NEWSWIRE) — via NewMediaWire – ABVC BioPharma, Inc. (NASDAQ:…
FREMONT, CA, July 26, 2023 (GLOBE NEWSWIRE) — via NewMediaWire – ABVC BioPharma, Inc. (NASDAQ:…
BERKELEY HEIGHTS, N.J., July 26, 2023 (GLOBE NEWSWIRE) — CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical…
BERKELEY HEIGHTS, N.J., July 26, 2023 (GLOBE NEWSWIRE) — CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical…
– Kriya’s therapeutic pipeline addresses a broad range of diseases that collectively affect millions of…
– Kriya’s therapeutic pipeline addresses a broad range of diseases that collectively affect millions of…
Dosing at Scientia Clinical Research has commenced with first male and female subjects dosed ahead…
Dosing at Scientia Clinical Research has commenced with first male and female subjects dosed ahead…
BEDMINSTER, N.J., July 26, 2023 (GLOBE NEWSWIRE) — Matinas BioPharma Holdings, Inc. Holdings, Inc. (NYSE American:…
BEDMINSTER, N.J., July 26, 2023 (GLOBE NEWSWIRE) — Matinas BioPharma Holdings, Inc. Holdings, Inc. (NYSE American:…
ZUG, Switzerland, and BOSTON, July 26, 2023 (GLOBE NEWSWIRE) — Oculis Holding AG (Nasdaq: OCS)…
ZUG, Switzerland, and BOSTON, July 26, 2023 (GLOBE NEWSWIRE) — Oculis Holding AG (Nasdaq: OCS)…
NEWARK, Calif., July 26, 2023 (GLOBE NEWSWIRE) — Rain Oncology Inc. (NasdaqGS: RAIN), (“Rain”) today…
NEWARK, Calif., July 26, 2023 (GLOBE NEWSWIRE) — Rain Oncology Inc. (NasdaqGS: RAIN), (“Rain”) today…
Full recruitment secures the target number of completer patients Multiple primary endpoints include reduction in…